Theriva Biologics (TOVX) Common Equity (2010 - 2026)
Theriva Biologics (TOVX) posted Common Equity of $12.19 million for Q2 2026, up 14.7% from $10.62 million a year earlier but down 20.9% from the prior quarter.
Powered by 
Analysis
Theriva Biologics (TOVX) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Theriva Biologics' Common Equity came in at $15.38 million, down 19.3% from FY2024.
- Annual Common Equity has declined for four consecutive years.
- In prior years, Theriva Biologics' Common Equity was $19.07 million in FY2024 (-48.4%), $36.96 million in FY2023 (-28.7%), $51.83 million in FY2022 (-20.8%) and $65.41 million in FY2021.
- Quarterly Common Equity has run from a low of $6.74 million in Q3 2025 to a high of $70.56 million in Q3 2021 over five years.
- On a year-over-year basis, Common Equity increased in 1 of the last eight quarters, with an average decline of 34.5%.
- The strongest year-over-year quarter for Common Equity in the past five years was Q2 2026, with growth of 14.7%; the weakest was Q3 2025, with a decline of 72.6%.
- According to Business Quant data, Common Equity for the three prior quarters was $15.4 million (Q1 2026), $15.38 million (Q4 2025) and $6.74 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Theriva Biologics | 10.10 Mn | 10.10 Mn | - | 12.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.19 Mn |
| Mar 31, 2026 | 15.40 Mn |
| Dec 31, 2025 | 15.38 Mn |
| Sep 30, 2025 | 6.74 Mn |
| Jun 30, 2025 | 10.62 Mn |
| Mar 31, 2025 | 15.50 Mn |
| Dec 31, 2024 | 19.07 Mn |
| Sep 30, 2024 | 24.64 Mn |
| Jun 30, 2024 | 25.90 Mn |
| Mar 31, 2024 | 31.39 Mn |
| Dec 31, 2023 | 36.96 Mn |
| Sep 30, 2023 | 41.15 Mn |
| Jun 30, 2023 | 45.02 Mn |
| Mar 31, 2023 | 47.85 Mn |
| Dec 31, 2022 | 51.83 Mn |
| Sep 30, 2022 | 56.39 Mn |
| Jun 30, 2022 | 62.22 Mn |
| Mar 31, 2022 | 68.03 Mn |
| Dec 31, 2021 | 65.41 Mn |
| Sep 30, 2021 | 70.56 Mn |
API Access
Theriva Biologics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=TOVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "TOVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=TOVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();